2005 Stock Overview
An investment holding company, researches, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally.
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 4/6 |
Past Performance | 5/6 |
Financial Health | 5/6 |
Dividends | 3/6 |
SSY Group Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | HK$4.75 |
52 Week High | HK$5.20 |
52 Week Low | HK$3.88 |
Beta | 0.61 |
1 Month Change | -1.86% |
3 Month Change | 1.71% |
1 Year Change | -7.41% |
3 Year Change | 0% |
5 Year Change | -28.68% |
Change since IPO | 1,139.13% |
Recent News & Updates
Recent updates
SSY Group (HKG:2005) Is Paying Out A Larger Dividend Than Last Year
Apr 29SSY Group's (HKG:2005) Upcoming Dividend Will Be Larger Than Last Year's
Apr 15SSY Group's (HKG:2005) Shareholders Will Receive A Bigger Dividend Than Last Year
Mar 31SSY Group Limited (HKG:2005) Just Released Its Annual Earnings: Here's What Analysts Think
Mar 29Does SSY Group (HKG:2005) Have A Healthy Balance Sheet?
Mar 28Here's Why We Think SSY Group (HKG:2005) Is Well Worth Watching
Mar 06Calculating The Intrinsic Value Of SSY Group Limited (HKG:2005)
Feb 13SSY Group Limited's (HKG:2005) Price In Tune With Earnings
Dec 29Does SSY Group (HKG:2005) Have A Healthy Balance Sheet?
Sep 26SSY Group (HKG:2005) Will Pay A Larger Dividend Than Last Year At HK$0.07
Sep 03If EPS Growth Is Important To You, SSY Group (HKG:2005) Presents An Opportunity
Aug 31Estimating The Intrinsic Value Of SSY Group Limited (HKG:2005)
Jun 24SSY Group (HKG:2005) Will Pay A Larger Dividend Than Last Year At HK$0.08
May 09SSY Group (HKG:2005) Will Pay A Larger Dividend Than Last Year At HK$0.08
Apr 04Does SSY Group (HKG:2005) Have A Healthy Balance Sheet?
Mar 29SSY Group Limited (HKG:2005) Shares Could Be 26% Below Their Intrinsic Value Estimate
Dec 21SSY Group (HKG:2005) Has A Pretty Healthy Balance Sheet
Dec 01SSY Group (HKG:2005) Will Pay A Larger Dividend Than Last Year At HK$0.06
Sep 15Shareholder Returns
2005 | HK Pharmaceuticals | HK Market | |
---|---|---|---|
7D | 1.9% | -0.8% | -0.4% |
1Y | -7.4% | -6.5% | -1.8% |
Return vs Industry: 2005 matched the Hong Kong Pharmaceuticals industry which returned -7.6% over the past year.
Return vs Market: 2005 underperformed the Hong Kong Market which returned -3.6% over the past year.
Price Volatility
2005 volatility | |
---|---|
2005 Average Weekly Movement | 5.9% |
Pharmaceuticals Industry Average Movement | 5.6% |
Market Average Movement | 7.2% |
10% most volatile stocks in HK Market | 15.3% |
10% least volatile stocks in HK Market | 3.7% |
Stable Share Price: 2005 has not had significant price volatility in the past 3 months.
Volatility Over Time: 2005's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1999 | 5,640 | Jiguang Qu | www.ssygroup.com.hk |
SSY Group Limited, an investment holding company, researches, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally. The company offers intravenous infusion solutions, including non-PVC soft bags, upright soft bags, PP plastic bottles, and glass bottle infusion solutions, as well as ampoule injections. It also provides small volume injections, oral preparations, Chinese medicine preparations, and biological preparations, as well as bulk pharmaceutical products and medical materials.
SSY Group Limited Fundamentals Summary
2005 fundamental statistics | |
---|---|
Market cap | HK$14.10b |
Earnings (TTM) | HK$1.32b |
Revenue (TTM) | HK$6.46b |
10.7x
P/E Ratio2.2x
P/S RatioIs 2005 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
2005 income statement (TTM) | |
---|---|
Revenue | HK$6.46b |
Cost of Revenue | HK$2.84b |
Gross Profit | HK$3.62b |
Other Expenses | HK$2.30b |
Earnings | HK$1.32b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 0.44 |
Gross Margin | 56.01% |
Net Profit Margin | 20.40% |
Debt/Equity Ratio | 46.3% |
How did 2005 perform over the long term?
See historical performance and comparison